Pharmacology of estrogens and progestogens: influence of different routes of administration

被引:544
作者
Kuhl, H [1 ]
机构
[1] Goethe Univ Frankfurt, Dept Obstet & Gynecol, D-60590 Frankfurt, Germany
关键词
estrogens; progestogens; pharmacokinetics; pharmacodynamics; hormone replacement therapy;
D O I
10.1080/13697130500148875
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
This review comprises the pharmacokinetics and pharmacodynamics of natural and synthetic estrogens and progestogens used in contraception and therapy, with special consideration of hormone replacement therapy. The paper describes the mechanisms of action, the relation between structure and hormonal activity, differences in hormonal pattern and potency, peculiarities in the properties of certain steroids, tissue-specific effects, and the metabolism of the available estrogens and progestogens. The influence of the route of administration on pharmacokinetics, hormonal activity and metabolism is presented, and the effects of oral and transdermal treatment with estrogens on tissues, clinical and serum parameters are compared. The effects of oral, transclermal (patch and gel), intranasal, sublingual, buccal, vaginal, subcutaneous and intramuscular administration of estrogens, as well as of oral, vaginal, transdermal, intranasal, buccal, intramuscular and intrauterine application of progestogens are discussed. The various types of progestogens, their receptor interaction, hormonal pattern and the hormonal activity of certain metabolites are described in detail. The structural formulae, serum concentrations, binding affinities to steroid receptors and serum binding globulins, and the relative potencies of the available estrogens and progestins are presented. Differences in the tissue-specific effects of the various compounds and regimens and their potential implications with the risks and benefits of hormone replacement therapy are discussed.
引用
收藏
页码:3 / 63
页数:61
相关论文
共 333 条
[1]  
ABDALLA HI, 1985, OBSTET GYNECOL, V66, P789
[2]   ORAL-CONTRACEPTIVES, LIPOPROTEINS, AND ATHEROSCLEROSIS [J].
ADAMS, MR ;
CLARKSON, TB ;
SHIVELY, CA ;
PARKS, JS ;
KAPLAN, JR .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (04) :1388-1393
[3]   Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis [J].
Adams, MR ;
Register, TC ;
Golden, DL ;
Wagner, JD ;
Williams, JK .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (01) :217-221
[4]  
ADAMS R M, 1970, Acta Dermato-Venereologica, V50, P479
[5]   PHARMACOKINETICS AND BIOTRANSFORMATION OF ORALLY-ADMINISTERED ESTRONE SULFATE AND ESTRADIOL VALERATE IN POSTMENOPAUSAL WOMEN [J].
AEDO, AR ;
LANDGREN, BM ;
DICZFALUSY, E .
MATURITAS, 1990, 12 (04) :333-343
[6]   Estrogen deficiency in severe postpartum depression:: Successful treatment with sublingual physiologic 17β-estradiol:: A preliminary study [J].
Ahokas, A ;
Kaukoranta, J ;
Wahlbeck, K ;
Aito, M .
JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (05) :332-336
[7]  
al-Azzawi F, 2001, Climacteric, V4, P343, DOI 10.1080/713605133
[8]   Continuous combined hormone replacement therapy compared with tibolone [J].
Al-Azzawi, F ;
Wahab, M ;
Habiba, M ;
Akkad, A ;
Mason, T .
OBSTETRICS AND GYNECOLOGY, 1999, 93 (02) :258-264
[9]   Purified phytoestrogens in postmenopausal bone health: is there a role for genistein? [J].
Albertazzi, P .
CLIMACTERIC, 2002, 5 (02) :190-196
[10]   Changes in normal lipid profit of menopausal women with combined hormone replacement therapy -: Comparative clinical trial of two hormonal combinations (conjugated estrogens medroxyprogesterone acetate versus estradiol valerate cyproterone acetate) [J].
Alwers, R ;
Urdinola, J ;
Onatra, W ;
Sánchez, F ;
Posso, H .
MATURITAS, 1999, 32 (01) :41-50